Credit Suisse’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-930,908
Closed -$5.61M 4386
2019
Q4
$5.61M Buy
930,908
+745,762
+403% +$4.32M ﹤0.01% 1806
2019
Q3
$666K Buy
185,146
+30,085
+19% +$116K ﹤0.01% 3267
2019
Q2
$415K Buy
155,061
+3,372
+2% +$9.96K ﹤0.01% 3513
2019
Q1
$450K Sell
151,689
-96,590
-39% -$237K ﹤0.01% 3395
2018
Q4
$396K Buy
248,279
+110,738
+81% +$313K ﹤0.01% 3381
2018
Q3
$506K Sell
137,541
-60,064
-30% -$179K ﹤0.01% 3289
2018
Q2
$559K Buy
197,605
+14,539
+8% +$49.5K ﹤0.01% 3365
2018
Q1
$679K Buy
183,066
+12,169
+7% +$39.8K ﹤0.01% 3192
2017
Q4
$491K Buy
170,897
+20,214
+13% +$73.4K ﹤0.01% 3444
2017
Q3
$677K Buy
150,683
+37,101
+33% +$165K ﹤0.01% 3361
2017
Q2
$522K Sell
113,582
-124,237
-52% -$499K ﹤0.01% 3132
2017
Q1
$1M Buy
237,819
+122,361
+106% +$508K ﹤0.01% 2862
2016
Q4
$477K Sell
115,458
-41,008
-26% -$218K ﹤0.01% 3476
2016
Q3
$1.27M Sell
156,466
-47,404
-23% -$403K ﹤0.01% 2758
2016
Q2
$1.59M Buy
203,870
+32,554
+19% +$279K ﹤0.01% 2525
2016
Q1
$1.32M Buy
171,316
+112,331
+190% +$823K ﹤0.01% 2518
2015
Q4
$637K Sell
58,985
-53,592
-48% -$487K ﹤0.01% 3192
2015
Q3
$778K Sell
112,577
-255,637
-69% -$2.08M ﹤0.01% 3059
2015
Q2
$3.26M Buy
368,214
+226,687
+160% +$2.14M ﹤0.01% 2134
2015
Q1
$1.4M Buy
141,527
+3,125
+2% +$39K ﹤0.01% 2708
2014
Q4
$1.7M Buy
138,402
+33,298
+32% +$407K ﹤0.01% 2685
2014
Q3
$1.05M Sell
105,104
-78,880
-43% -$732K ﹤0.01% 3004
2014
Q2
$1.39M Buy
183,984
+88,368
+92% +$353K ﹤0.01% 3010
2014
Q1
$315K Sell
95,616
-108,798
-53% -$381K ﹤0.01% 4061
2013
Q4
$679K Sell
204,414
-32,955
-14% -$95.6K ﹤0.01% 3565
2013
Q3
$716K Sell
237,369
-11,917
-5% -$81.7K ﹤0.01% 3230
2013
Q2
$2.04M Buy
+249,286
New +$1.9M ﹤0.01% 2254